ADS-ADEA 2015*
Chairs: Spiros Fourlanos & Sarah Price
Intestinal fatty acid sensor (FFAR4) and transporter (CD36) expression are significantly correlated with body mass index, and are not altered by acute fat exposure in lean, overweight or obese humans (#6)
8:30 AM
Predictors of susceptibility to weight change during a single cycle of weight gain and loss (#7)
8:45 AM
Increased Capacity for Intestinal Serotonin Release in Obese and Diabetic Humans (#8)
9:00 AM
Liraglutide 3.0 mg for weight management in obese/overweight adults with type 2 diabetes: Results from the SCALE Diabetes 56-week randomised, double-blind, placebo-controlled trial (#9)
9:15 AM
Additional analyses of the weight-lowering efficacy of liraglutide 3.0 mg in overweight and obese adults: the SCALE Obesity and Prediabetes randomised trial (#10)
9:30 AM
Differences in postpartum weight retention in Caucasian, Oriental and Indian-Subcontinental women, 3 months following a GDM pregnancy. Causes, and implications for future risk. (#11)
9:45 AM
Pregnancy Outcomes in Women with Gestational Diabetes under the Old ADIPS and New IADPSG Diagnostic Criterias (#12)
10:00 AM
Tackling the burden of youth onset Type 2 diabetes: a pilot collaborative study in tertiary and primary care settings (#13)
10:15 AM